You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS<br />
Research Pipeline for Novartis<br />
R&D Profile<br />
Compound Code Class Phase<br />
filgrastim — L3A1 Approved<br />
vaccine, pandemic influenza, Novartis — J7A1 Approved<br />
aliskiren + valsartan — C9X, C9D9 Filed<br />
canakinumab ACZ 885 M1C, R3X, V3X, S1P Filed<br />
efungumab — J2A, L1X3 Filed<br />
indacaterol QAB 149 R3A Filed<br />
vaccine, Japanese encephalitis virus,<br />
Intercell IC51 J7A9 Filed<br />
vaccine, meningococcal ACWY, Novartis MenACWY J7A8 Filed<br />
valsartan + amlodipine + HCTZ — C9D3 Filed<br />
agomelatine AGO 178 N6A, N5B III<br />
albinterferon alfa-2b ABF 656 J5B, L3B1 III<br />
aliskiren + amlodipine — C9X, C8A III<br />
aliskiren + amlodipine + HCTZ — C9X, C8A, C3A III<br />
drug delivery system, NexACT,<br />
terbinafine, Novartis NM 100060 D1A, V7A III<br />
drug delivery system, oral salmon<br />
calcitonin, Emisphere/Novartis SMC 021 H4A, V7A III<br />
drug delivery system, poliglumex<br />
paclitaxel CT 2103, PG-TXL, CHC 12103 L1C, V7A III<br />
fingolimod FTY 720 L4A, N7X III<br />
formoterol + mometasone MFF 258 R3F III<br />
midostaurin PKC 412, CGP 41251 L1X9, S1X III<br />
pasireotide SOM 230 L2A9 III<br />
patupilone EPO 906 L1D III<br />
tifacogin TFP 561 V3X, J1X9 III<br />
vaccine, Neisseria meningitidis group B,<br />
Novartis MenB J7A8 III<br />
vaccine, pre-pandemic influenza,<br />
Novartis — J7A1 III<br />
vadimezan ASA 404, AS 1404 L1X9 III<br />
antipsychotic AQW 051 N5A9, N7D9 II<br />
ARB/NEP blocker LCZ 696 C2A, C9C II<br />
asthma and COPD therapy QAE 397 R3X II<br />
asthma/COPD therapy QAT 370 R3G II<br />
cancer therapy AUY 922 L1X9 II<br />
cannabinoid receptor agonist SAB 378 N7X II<br />
carbapenem antibiotic PTZ 601, SMP 601, SM 216601 J1P2 II<br />
cystic fibrosis therapy QAU 145 R7X II<br />
drug delivery system, indacaterol +<br />
glycopyrronium bromide QVA 149 R3G, V7A II<br />
drug delivery system, inhaled<br />
glycopyrronium bromide NVA 237, AD 237 R7X II<br />
elinogrel PRT 060128 B1C2, C1D II<br />
gimatecan ST 1481, CPT 184, LBQ 707 L1X9 II<br />
glaucoma therapy Y 39983 S1E II<br />
HCV therapy IDX 184 J5B1 II<br />
indacaterol + mometasone QMF 149 R3F II<br />
lucatumumab HCD 122 L1X9 II<br />
MAb, CSF1, Novartis MCS 110 L1X3 II<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 74
Change language